Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003) 

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. AMD
6. GOOG
7. INTC
8. CSX
9. KNX
10. IBM

Go back to Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003) 
(NYSE: NSRX) Delayed: 3.09 +0.18 (6.19%)
Previous Close $2.91    52 Week High $ 
Open $2.90    52 Week Low $ 
Day High $3.09    P/E N/A 
Day Low $2.87    EPS $ 
Volume 9,650